“To develop an effective treatment for Alzheimer's disease, we need to tackle multiple aspects of the disease. KCL-286 was able to target multiple disease-relevant cellular pathways, some of which are initiated very early in the disease course.”

Natasha Hill · said date not stated · reported 2026-11-03

Natasha Hill said KCL-286 targets multiple disease-relevant cellular pathways initiated early in the Alzheimer's disease course.